{"id":8767,"date":"2023-12-05T11:14:32","date_gmt":"2023-12-05T19:14:32","guid":{"rendered":"https:\/\/acsr1.com\/?p=8767"},"modified":"2026-04-09T19:22:41","modified_gmt":"2026-04-10T02:22:41","slug":"new-from-nci-minute-combomatch","status":"publish","type":"post","link":"https:\/\/www.acsr1.com\/?p=8767","title":{"rendered":"NEW from NCI Minute: ComboMatch"},"content":{"rendered":"\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe loading=\"lazy\" title=\"NCI Minute: Precision Medicine Cancer Initiative\" width=\"800\" height=\"450\" src=\"https:\/\/www.youtube.com\/embed\/aZyV65dQGkc?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" allowfullscreen><\/iframe>\n<\/div><\/figure>\n\n\n\n<p class=\"has-medium-font-size\">Learn more about ComboMATCH: the new clinical trial initiative to evaluate combinations&nbsp;of treatments that block both the drivers of tumor growth&nbsp;and the mechanisms of resistance.<\/p>\n\n\n\n<p class=\"has-medium-font-size\">The primary goal for ComboMATCH is to see whether the use of drug combinations can overcome the resistance to treatment that can arise with the use of a single drug that targets a genetic change. Each drug combination tested in ComboMATCH was selected based on strong evidence of its promise to improve patient outcomes.<\/p>\n\n\n\n<p class=\"has-medium-font-size\">ComboMATCH is supported by NCI and is coordinated by the ECOG-ACRIN Cancer Research GroupExit Disclaimer. Personnel from NCI, ECOG-ACRIN, and the other U.S. trial groups in NCI&#8217;s National Clinical Trials Network (NCTN)\u2014the Alliance for Clinical Trials in OncologyExit Disclaimer, NRG Oncology GroupExit Disclaimer, the SWOG Cancer Research NetworkExit Disclaimer, and the Children\u2019s Oncology GroupExit Disclaimer\u2014 collaborated to develop ComboMATCH.<\/p>\n\n\n\n<p class=\"has-medium-font-size\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Learn more about ComboMATCH: the new clinical trial initiative to evaluate combinations&nbsp;of treatments that block both the drivers of tumor growth&nbsp;and the mechanisms of resistance. The primary goal for ComboMATCH &#8230;<\/p>\n","protected":false},"author":2,"featured_media":8770,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false},"categories":[1],"tags":[142,256,346,27],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 4.9.10 - aioseo.com -->\n\t<meta name=\"description\" content=\"Learn more about ComboMATCH: the new clinical trial initiative to evaluate combinations of treatments that block both the drivers of tumor growth and the mechanisms of resistance. The primary goal for ComboMATCH is to see whether the use of drug combinations can overcome the resistance to treatment that can arise with the use of a single drug\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"WebmasterHIIRS\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.acsr1.com\/?p=8767\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 4.9.10\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"AIDS and Cancer Specimen Resource | HIV Malignancy Specimens for Research at No Charge\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"NEW from NCI Minute: ComboMatch | AIDS and Cancer Specimen Resource\" \/>\n\t\t<meta property=\"og:description\" content=\"Learn more about ComboMATCH: the new clinical trial initiative to evaluate combinations of treatments that block both the drivers of tumor growth and the mechanisms of resistance. The primary goal for ComboMATCH is to see whether the use of drug combinations can overcome the resistance to treatment that can arise with the use of a single drug\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.acsr1.com\/?p=8767\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/www.acsr1.com\/wp-content\/uploads\/2017\/04\/cropped-cropped-ACSR_Color-Logo128-e1491856853898.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/www.acsr1.com\/wp-content\/uploads\/2017\/04\/cropped-cropped-ACSR_Color-Logo128-e1491856853898.png\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2023-12-05T19:14:32+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-04-10T02:22:41+00:00\" \/>\n\t\t<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/acsrbiobank\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary\" \/>\n\t\t<meta name=\"twitter:site\" content=\"@ACSRbiobank\" \/>\n\t\t<meta name=\"twitter:title\" content=\"NEW from NCI Minute: ComboMatch | AIDS and Cancer Specimen Resource\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Learn more about ComboMATCH: the new clinical trial initiative to evaluate combinations of treatments that block both the drivers of tumor growth and the mechanisms of resistance. The primary goal for ComboMATCH is to see whether the use of drug combinations can overcome the resistance to treatment that can arise with the use of a single drug\" \/>\n\t\t<meta name=\"twitter:creator\" content=\"@ACSRbiobank\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/www.acsr1.com\/wp-content\/uploads\/2017\/04\/cropped-cropped-ACSR_Color-Logo128-e1491856853898.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.acsr1.com\\\/?p=8767#article\",\"name\":\"NEW from NCI Minute: ComboMatch | AIDS and Cancer Specimen Resource\",\"headline\":\"NEW from NCI Minute: ComboMatch\",\"author\":{\"@id\":\"https:\\\/\\\/www.acsr1.com\\\/?author=2#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/www.acsr1.com\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.acsr1.com\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/ThisJustIn.png\",\"width\":597,\"height\":372,\"caption\":\"Graphic of a lightening bolt with the caption: \\\"This just in, new research news\\\"\"},\"datePublished\":\"2023-12-05T11:14:32-08:00\",\"dateModified\":\"2026-04-09T19:22:41-07:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.acsr1.com\\\/?p=8767#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.acsr1.com\\\/?p=8767#webpage\"},\"articleSection\":\"Uncategorized, Cancer research, Clinical Trials, ComboMATCH, NCI\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.acsr1.com\\\/?p=8767#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.acsr1.com#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.acsr1.com\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.acsr1.com\\\/?cat=1#listItem\",\"name\":\"Uncategorized\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.acsr1.com\\\/?cat=1#listItem\",\"position\":2,\"name\":\"Uncategorized\",\"item\":\"https:\\\/\\\/www.acsr1.com\\\/?cat=1\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.acsr1.com\\\/?p=8767#listItem\",\"name\":\"NEW from NCI Minute: ComboMatch\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.acsr1.com#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.acsr1.com\\\/?p=8767#listItem\",\"position\":3,\"name\":\"NEW from NCI Minute: ComboMatch\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.acsr1.com\\\/?cat=1#listItem\",\"name\":\"Uncategorized\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.acsr1.com\\\/#organization\",\"name\":\"AIDS and Cancer Specimen Resource\",\"description\":\"HIV Malignancy Specimens for Research at No Charge\",\"url\":\"https:\\\/\\\/www.acsr1.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.acsr1.com\\\/wp-content\\\/uploads\\\/2017\\\/04\\\/cropped-cropped-ACSR_Color-Logo128-e1491856853898.png\",\"@id\":\"https:\\\/\\\/www.acsr1.com\\\/?p=8767\\\/#organizationLogo\",\"width\":250,\"height\":182},\"image\":{\"@id\":\"https:\\\/\\\/www.acsr1.com\\\/?p=8767\\\/#organizationLogo\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/acsrbiobank\",\"https:\\\/\\\/twitter.com\\\/ACSRbiobank\",\"https:\\\/\\\/www.instagram.com\\\/acsrbiobank\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/in\\\/aids-and-cancer-specimen-resource\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.acsr1.com\\\/?author=2#author\",\"url\":\"https:\\\/\\\/www.acsr1.com\\\/?author=2\",\"name\":\"WebmasterHIIRS\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/www.acsr1.com\\\/?p=8767#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/472ae694e3e0a5cace43ba5d9fb1a0f1?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"WebmasterHIIRS\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.acsr1.com\\\/?p=8767#webpage\",\"url\":\"https:\\\/\\\/www.acsr1.com\\\/?p=8767\",\"name\":\"NEW from NCI Minute: ComboMatch | AIDS and Cancer Specimen Resource\",\"description\":\"Learn more about ComboMATCH: the new clinical trial initiative to evaluate combinations of treatments that block both the drivers of tumor growth and the mechanisms of resistance. The primary goal for ComboMATCH is to see whether the use of drug combinations can overcome the resistance to treatment that can arise with the use of a single drug\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.acsr1.com\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.acsr1.com\\\/?p=8767#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/www.acsr1.com\\\/?author=2#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/www.acsr1.com\\\/?author=2#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.acsr1.com\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/ThisJustIn.png\",\"@id\":\"https:\\\/\\\/www.acsr1.com\\\/?p=8767\\\/#mainImage\",\"width\":597,\"height\":372,\"caption\":\"Graphic of a lightening bolt with the caption: \\\"This just in, new research news\\\"\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.acsr1.com\\\/?p=8767#mainImage\"},\"datePublished\":\"2023-12-05T11:14:32-08:00\",\"dateModified\":\"2026-04-09T19:22:41-07:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.acsr1.com\\\/#website\",\"url\":\"https:\\\/\\\/www.acsr1.com\\\/\",\"name\":\"AIDS and Cancer Specimen Resource\",\"description\":\"HIV Malignancy Specimens for Research at No Charge\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.acsr1.com\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"NEW from NCI Minute: ComboMatch | AIDS and Cancer Specimen Resource","description":"Learn more about ComboMATCH: the new clinical trial initiative to evaluate combinations of treatments that block both the drivers of tumor growth and the mechanisms of resistance. The primary goal for ComboMATCH is to see whether the use of drug combinations can overcome the resistance to treatment that can arise with the use of a single drug","canonical_url":"https:\/\/www.acsr1.com\/?p=8767","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.acsr1.com\/?p=8767#article","name":"NEW from NCI Minute: ComboMatch | AIDS and Cancer Specimen Resource","headline":"NEW from NCI Minute: ComboMatch","author":{"@id":"https:\/\/www.acsr1.com\/?author=2#author"},"publisher":{"@id":"https:\/\/www.acsr1.com\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/www.acsr1.com\/wp-content\/uploads\/2023\/12\/ThisJustIn.png","width":597,"height":372,"caption":"Graphic of a lightening bolt with the caption: \"This just in, new research news\""},"datePublished":"2023-12-05T11:14:32-08:00","dateModified":"2026-04-09T19:22:41-07:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/www.acsr1.com\/?p=8767#webpage"},"isPartOf":{"@id":"https:\/\/www.acsr1.com\/?p=8767#webpage"},"articleSection":"Uncategorized, Cancer research, Clinical Trials, ComboMATCH, NCI"},{"@type":"BreadcrumbList","@id":"https:\/\/www.acsr1.com\/?p=8767#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.acsr1.com#listItem","position":1,"name":"Home","item":"https:\/\/www.acsr1.com","nextItem":{"@type":"ListItem","@id":"https:\/\/www.acsr1.com\/?cat=1#listItem","name":"Uncategorized"}},{"@type":"ListItem","@id":"https:\/\/www.acsr1.com\/?cat=1#listItem","position":2,"name":"Uncategorized","item":"https:\/\/www.acsr1.com\/?cat=1","nextItem":{"@type":"ListItem","@id":"https:\/\/www.acsr1.com\/?p=8767#listItem","name":"NEW from NCI Minute: ComboMatch"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.acsr1.com#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/www.acsr1.com\/?p=8767#listItem","position":3,"name":"NEW from NCI Minute: ComboMatch","previousItem":{"@type":"ListItem","@id":"https:\/\/www.acsr1.com\/?cat=1#listItem","name":"Uncategorized"}}]},{"@type":"Organization","@id":"https:\/\/www.acsr1.com\/#organization","name":"AIDS and Cancer Specimen Resource","description":"HIV Malignancy Specimens for Research at No Charge","url":"https:\/\/www.acsr1.com\/","logo":{"@type":"ImageObject","url":"https:\/\/www.acsr1.com\/wp-content\/uploads\/2017\/04\/cropped-cropped-ACSR_Color-Logo128-e1491856853898.png","@id":"https:\/\/www.acsr1.com\/?p=8767\/#organizationLogo","width":250,"height":182},"image":{"@id":"https:\/\/www.acsr1.com\/?p=8767\/#organizationLogo"},"sameAs":["https:\/\/www.facebook.com\/acsrbiobank","https:\/\/twitter.com\/ACSRbiobank","https:\/\/www.instagram.com\/acsrbiobank\/","https:\/\/www.linkedin.com\/in\/aids-and-cancer-specimen-resource\/"]},{"@type":"Person","@id":"https:\/\/www.acsr1.com\/?author=2#author","url":"https:\/\/www.acsr1.com\/?author=2","name":"WebmasterHIIRS","image":{"@type":"ImageObject","@id":"https:\/\/www.acsr1.com\/?p=8767#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/472ae694e3e0a5cace43ba5d9fb1a0f1?s=96&d=mm&r=g","width":96,"height":96,"caption":"WebmasterHIIRS"}},{"@type":"WebPage","@id":"https:\/\/www.acsr1.com\/?p=8767#webpage","url":"https:\/\/www.acsr1.com\/?p=8767","name":"NEW from NCI Minute: ComboMatch | AIDS and Cancer Specimen Resource","description":"Learn more about ComboMATCH: the new clinical trial initiative to evaluate combinations of treatments that block both the drivers of tumor growth and the mechanisms of resistance. The primary goal for ComboMATCH is to see whether the use of drug combinations can overcome the resistance to treatment that can arise with the use of a single drug","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/www.acsr1.com\/#website"},"breadcrumb":{"@id":"https:\/\/www.acsr1.com\/?p=8767#breadcrumblist"},"author":{"@id":"https:\/\/www.acsr1.com\/?author=2#author"},"creator":{"@id":"https:\/\/www.acsr1.com\/?author=2#author"},"image":{"@type":"ImageObject","url":"https:\/\/www.acsr1.com\/wp-content\/uploads\/2023\/12\/ThisJustIn.png","@id":"https:\/\/www.acsr1.com\/?p=8767\/#mainImage","width":597,"height":372,"caption":"Graphic of a lightening bolt with the caption: \"This just in, new research news\""},"primaryImageOfPage":{"@id":"https:\/\/www.acsr1.com\/?p=8767#mainImage"},"datePublished":"2023-12-05T11:14:32-08:00","dateModified":"2026-04-09T19:22:41-07:00"},{"@type":"WebSite","@id":"https:\/\/www.acsr1.com\/#website","url":"https:\/\/www.acsr1.com\/","name":"AIDS and Cancer Specimen Resource","description":"HIV Malignancy Specimens for Research at No Charge","inLanguage":"en-US","publisher":{"@id":"https:\/\/www.acsr1.com\/#organization"}}]},"og:locale":"en_US","og:site_name":"AIDS and Cancer Specimen Resource | HIV Malignancy Specimens for Research at No Charge","og:type":"article","og:title":"NEW from NCI Minute: ComboMatch | AIDS and Cancer Specimen Resource","og:description":"Learn more about ComboMATCH: the new clinical trial initiative to evaluate combinations of treatments that block both the drivers of tumor growth and the mechanisms of resistance. The primary goal for ComboMATCH is to see whether the use of drug combinations can overcome the resistance to treatment that can arise with the use of a single drug","og:url":"https:\/\/www.acsr1.com\/?p=8767","og:image":"https:\/\/www.acsr1.com\/wp-content\/uploads\/2017\/04\/cropped-cropped-ACSR_Color-Logo128-e1491856853898.png","og:image:secure_url":"https:\/\/www.acsr1.com\/wp-content\/uploads\/2017\/04\/cropped-cropped-ACSR_Color-Logo128-e1491856853898.png","article:published_time":"2023-12-05T19:14:32+00:00","article:modified_time":"2026-04-10T02:22:41+00:00","article:publisher":"https:\/\/www.facebook.com\/acsrbiobank","twitter:card":"summary","twitter:site":"@ACSRbiobank","twitter:title":"NEW from NCI Minute: ComboMatch | AIDS and Cancer Specimen Resource","twitter:description":"Learn more about ComboMATCH: the new clinical trial initiative to evaluate combinations of treatments that block both the drivers of tumor growth and the mechanisms of resistance. The primary goal for ComboMATCH is to see whether the use of drug combinations can overcome the resistance to treatment that can arise with the use of a single drug","twitter:creator":"@ACSRbiobank","twitter:image":"https:\/\/www.acsr1.com\/wp-content\/uploads\/2017\/04\/cropped-cropped-ACSR_Color-Logo128-e1491856853898.png"},"aioseo_meta_data":{"post_id":"8767","title":null,"description":null,"keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":{"id":"#aioseo-article-65cab7ac9d620","slug":"article","graphName":"Article","label":"Article","properties":{"type":"BlogPosting","name":"#post_title","headline":"#post_title","description":"#post_excerpt","image":"","keywords":"","author":{"name":"#author_name","url":"#author_url"},"dates":{"include":true,"datePublished":"","dateModified":""}}},"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"Article","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":"{\"article\":{\"articleType\":\"BlogPosting\"},\"course\":{\"name\":\"\",\"description\":\"\",\"provider\":\"\"},\"faq\":{\"pages\":[]},\"product\":{\"reviews\":[]},\"recipe\":{\"ingredients\":[],\"instructions\":[],\"keywords\":[]},\"software\":{\"reviews\":[],\"operatingSystems\":[]},\"webPage\":{\"webPageType\":\"WebPage\"},\"blockGraphs\":[]}","pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":{"faqs":[],"keyPoints":[],"titles":[],"descriptions":[],"socialPosts":{"email":[],"linkedin":[],"twitter":[],"facebook":[],"instagram":[]}},"created":"2023-12-05 17:53:06","updated":"2026-04-10 02:23:15","seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.acsr1.com\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.acsr1.com\/?cat=1\" title=\"Uncategorized\">Uncategorized<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tNEW from NCI Minute: ComboMatch\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.acsr1.com"},{"label":"Uncategorized","link":"https:\/\/www.acsr1.com\/?cat=1"},{"label":"NEW from NCI Minute: ComboMatch","link":"https:\/\/www.acsr1.com\/?p=8767"}],"_links":{"self":[{"href":"https:\/\/www.acsr1.com\/index.php?rest_route=\/wp\/v2\/posts\/8767"}],"collection":[{"href":"https:\/\/www.acsr1.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.acsr1.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.acsr1.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.acsr1.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=8767"}],"version-history":[{"count":5,"href":"https:\/\/www.acsr1.com\/index.php?rest_route=\/wp\/v2\/posts\/8767\/revisions"}],"predecessor-version":[{"id":9122,"href":"https:\/\/www.acsr1.com\/index.php?rest_route=\/wp\/v2\/posts\/8767\/revisions\/9122"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.acsr1.com\/index.php?rest_route=\/wp\/v2\/media\/8770"}],"wp:attachment":[{"href":"https:\/\/www.acsr1.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=8767"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.acsr1.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=8767"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.acsr1.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=8767"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}